Global Custom Market Research Reports Provider Company

phone

Partnerships, Licensing, Investments and M&A Deals and Trends for December 2017 in Pharmaceuticals

  • Published Date: 02 Feb 2018
  • Number of Pages: 88
  • Category: Pharmaceuticals
  • Country: Global

Partnerships, Licensing, Investments and M&A Deals and Trends for December 2017 in Pharmaceuticals

Summary

GlobalDatas ""Partnerships, Licensing, Investments and M&A Deals and Trends for December 2017 in Pharmaceuticals"", report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in December 2017. The report portrays detailed comparative data on the number of deals and their value in the last six months, subdivided by deal types, various therapy areas, and geographies. Additionally, the report provides information on the top financial advisory firms in the pharmaceuticals industry.

Data presented in this report is derived from GlobalData’s proprietary in-house Pharmaceuticals eTrack deals database and primary and secondary research.

The pharmaceutical and healthcare industry reported a decrease in the number of deals and deal values in December 2017. The industry reported 375 deals worth USD21 billion in December 2017, compared to 403 deals worth USD27.5 billion in November 2017. The oncology therapeutics market remained at the top in deal activity in December 2017 with 124 deals. In second place, central nervous system therapeutics market reported 77 deals. Licensing agreements in pharmaceutical and healthcare industry registered an increase in upfront payments. The segment reported USD551.2m as upfront payments in December 2017, compared to USD185.9m in November 2017. The number of deals in North America a decreased to 210 in December 2017 from 241 in November 2017.

Scope

- Analysis of the market trends for the pharmaceutical industry in the global arena.
- Review of deal trends in the cardiovascular, central nervous system, dermatology, ear nose throat disorders, gastrointestinal, genito urinary system and sex hormones, hematological disorders, hormonal disorders, immunology, infectious disease, male health, metabolic disorders, mouth and dental disorders, musculoskeletal, oncology, ophthalmology, respiratory, toxicology, and womens health segments.
- Analysis of partnerships, licensing, M&As, equity/debt offerings, private equity, and venture financing deals in the pharmaceutical industry.
- Analysis of therapy areas which are very active in terms of venture capital financing, partnerships, licensing agreements, equity/debt offerings, and M&As.
- Analysis of deals based on different payment modes, including upfront and milestone payments, primarily in partnerships and licensing agreements in the pharmaceutical industry.
- Analysis of partnership and licensing deals based on clinical stage of development of products.
- Summary of the pharmaceutical deals globally in the six months.
- Information on the top deals happened in the pharmaceutical industry.
- Geographies covered include - North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa.
- League tables of financial advisors in M&As and equity/debt offerings. This includes key advisors such as Morgan Stanley, Credit Suisse, and Goldman Sachs.

Reasons to buy

- Enhance your decision making capability in a more rapid and time sensitive manner.
- Find out the major deal performing segments for investments in your industry.
- Evaluate the types of companies which are entering into partnership or licensing agreements; divesting and acquiring assets.
- Identify companies that are aggressively looking to raise capital in the market
- Evaluate niche therapy areas that are receiving majority of the upfront and milestone payments in the pharmaceutical industry.
- Identify the key venture capitalists, who are financing the pharmaceutical and biotech companies.
- Evaluate the clinical development stages where majority of the partnerships and licensing agreements are happening.
- Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the pharmaceutical industry.
- Identify growth segments and opportunities in each region within the industry.
- Look for key financial advisors where you are planning to raise capital from the market or for acquisitions within the industry.
 

Publisher Name : GlobalData


1.1 List of Tables 5
1.2 List of Figures 7
2 Pharmaceuticals & Healthcare, Global, Deal Summary 10
2.1 Pharmaceuticals & Healthcare, Global, Deal Analysis, December 2017 10
2.2 Pharmaceuticals & Healthcare, Global, Major Deals, December 2017 12
2.2.1 Nestle to Acquire Atrium Innovations for USD2.3 Billion 12
2.2.2 Roche to Acquire Ignyta for USD1.7 Billion 12
2.2.3 Mallinckrodt to Acquire Sucampo Pharma for USD1.2 Billion 13
2.2.4 AskAt Enters into Licensing Agreement with Arrys Therapeutics 14
2.2.5 Valeant Pharma Raises USD1.18 Billion in Private Placement of 9% Notes Due 2025 15
2.3 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, December 2017 16
2.4 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, December 2017 17
3 Pharmaceuticals and Healthcare, Global, Deals, Summary, by Type 18
3.1 Pharmaceuticals & Healthcare, Global, M&A, December 2017 18
3.1.1 Top M&A Deals in December 2017 19
3.1.2 Pharmaceuticals & Healthcare, Global, M&A Deals by Therapy Area, July 2017 - December 2017 20
3.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, December 2017 21
3.2.1 Top Equity Offering Deals in December 2017 22
3.2.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals by Therapy Area, July 2017 - December 2017 23
3.3 Pharmaceuticals & Healthcare, Global, Private Equity and Venture Capital Deals, December 2017 24
3.3.1 Top PE/VC Deals in December 2017 25
3.3.2 Pharmaceuticals & Healthcare, Global, PE/VC by Therapy Area, December 2017 26
3.3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, December 2017 27
3.3.4 Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, June 2016-December 2017 29
3.3.5 Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, June 2016-December 2017 30
3.4 Pharmaceuticals & Healthcare, Global, Partnership Deals, December 2017 31
3.5 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, July 2017 - December 2017 32
3.6 Pharmaceuticals & Healthcare, Global, Partnership Deals by Upfront and Milestone Payments and Deal Values (US$ m), December 2017 33
3.6.1 Pharmaceuticals & Healthcare, Global, Top Partnership Deals by Payment Mode, December 2017 34
3.7 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, by Upfront and Milestone Payments and Deal Values (US$ m), July 2017 - December 2017 35
3.8 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Number Of Deals, July 2017 - December 2017 37
3.9 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Deal Values (US$ m), July 2017 - December 2017 38
3.10 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), July 2017 - December 2017 39
4 Pharmaceuticals & Healthcare, Global, Licensing Agreements, December 2017 41
4.1 Pharmaceuticals & Healthcare, Global, Licensing Agreements, December 2017 41
4.2 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront and Milestone Payments and Deal Values (US$ m), December 2017 43
4.3 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Total Deal Values (US$ m), July 2017 - December 2017 45
4.4 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Upfront Payments and Milestone Payments (US$ m), July 2017 - December 2017 47
4.5 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Total Deal Values (US$ m), July 2017 - December 2017 49
4.6 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Upfront Payments and Milestone Payments (US$ m), July 2017 - December 2017 52
4.6.1 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Deal Value, December 2017 53
4.6.2 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Upfront Payments, December 2017 54
4.6.3 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Total Milestone Payment, December 2017 54
5 Pharmaceuticals & Healthcare, Global, Deal Summary by Therapy Area 55
5.1 Pharmaceuticals & Healthcare, Global, Oncology Deals, December 2017 55
5.1.1 Oncology - Deals of the Month 56
5.2 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, December 2017 58
5.2.1 Central Nervous System - Deals of the Month 59
5.3 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, December 2017 61
5.3.1 Infectious Diseases - Deals of the Month 62
5.4 Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, December 2017 64
5.4.1 Cardiovascular - Deal of the Month 65
5.5 Pharmaceuticals & Healthcare, Global, Immunology Deals, December 2017 66
5.5.1 Immunology - Deals of the Month 67
5.6 Pharmaceuticals & Healthcare, Global, Gastrointestinal Deals, December 2017 68
5.6.1 Gastrointestinal - Deal of the Month 69
5.7 Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Deals, December 2017 71
5.7.1 Metabolic Disorders - Deal of the Month 72
6 Deal Summary by Geography 73
6.1 Pharmaceuticals & Healthcare, North America Deals, December 2017 73
6.1.1 North America - Deals of the Month 74
6.2 Pharmaceuticals & Healthcare, Europe, Deals, December 2017 76
6.2.1 Europe - Deals of the Month 77
6.3 Pharmaceuticals & Healthcare, Asia-Pacific, Regional Deals, December 2017 79
6.3.1 Asia-Pacific - Deals of the Month 80
6.4 Pharmaceuticals & Healthcare, Rest of the World, Deals, December 2017 81
6.4.1 Rest of the World - Deals of the Month 82
7 Pharmaceuticals & Healthcare, Global, Top Financial Advisors 83
7.1 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, M&A, July 2017 - December 2017 83
7.2 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, July 2017 - December 2017 85
8 Further Information 86
8.1 Methodology 86
8.2 About GlobalData 87
8.3 Contact Us 87
8.4 Disclosure information 87
8.5 Disclaimer 88
 



List Of Tables

1.1 List of Tables
Table 1: Pharmaceuticals & Healthcare, Global, Deals Summary, Number of Deals and Deal Values (US$ m), July 2017 - December 2017 11
Table 2: Pharmaceuticals & Healthcare, Global, Major Deals, December 2017 12
Table 3: Pharmaceuticals & Healthcare, Global, Number Of Deals and Deal Values (%), December 2017 17
Table 4: Pharmaceuticals & Healthcare, Global, M&A, Deals Summary, Number of Deals and Deal Values (US$ m), July 2017 - December 2017 19
Table 5: Pharmaceuticals & Healthcare, Global, Top M&A Deals, December 2017 19
Table 6: Pharmaceuticals & Healthcare, Global, M&A, Deals Summary, Number of Deals and Deal Values (US$ m), by Therapy Area, July 2017 - December 2017 20
Table 7: Pharmaceuticals & Healthcare, Global, Equity Offerings, Deals Summary, Number of Deals and Deal Values (US$ m), July 2017 - December 2017 22
Table 8: Pharmaceuticals & Healthcare, Global, Top Equity Offering Deals, December 2017 22
Table 9: Pharmaceuticals & Healthcare, Global, Equity Offering Deals, Deals Summary, Number of Deals and Deal Values (US$ m), July 2017 - December 2017 23
Table 10: Pharmaceuticals & Healthcare, Global, PE/VC, Deals Summary, Number of Deals and Deal Values (US$ m), July 2017 - December 2017 25
Table 11: Pharmaceuticals & Healthcare, Global, Top PE/VC Deals, December 2017 25
Table 12: Pharmaceuticals & Healthcare, Global, PE/VC Deals by Therapy Area, Deals Summary, July 2017 - December 2017 26
Table 13: Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, Number Of Deals and Deal Values (%), December 2017 28
Table 14: Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, Number of Deals and Deal Values (US$ m), July 2017 - December 2017 29
Table 15: Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, July 2017 - December 2017 30
Table 16: Pharmaceuticals & Healthcare, Global, Partnerships, Number of Deals and Deal Values (US$ m), July 2017 - December 2017 31
Table 17: Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, Number of Deals and Deal Values (US$ m), July 2017 - December 2017 32
Table 18: Pharmaceuticals & Healthcare, Partnership Deals, Upfront and Milestone Payments and Deal Values (US$ m), July 2017 - December 2017 33
Table 19: Pharmaceuticals & Healthcare, Global, Partnerships, Upfront and Milestone Payments and Deal Values (US$ m), December 2017 34
Table 20: Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, Upfront and Milestone Payments and Deal Values (US$ m), July 2017 - December 2017 36
Table 21: Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, July 2017 - December 2017 38
Table 22: Pharmaceuticals & Healthcare, Global, Partnership Deals by Upfront and Milestone Payment and Deal values (US$ m), July 2017 - December 2017 40
Table 23: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Deals Summary, Number of Deals and Deal Values (US$ m), July 2017 - December 2017 42
Table 24: Pharmaceuticals & Healthcare, Global, Licensing Agreements, Deals Summary, Upfront and Milestone Payments and Deal Values (US$ m), July 2017 - December 2017 44
Table 25: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Number of Deals and Deal Values (US$ m), July 2017 - December 2017 46
Table 26:Pharmaceuticals & Healthcare, Global, Licensing Agreements by Therapy Area, by Upfront and Milestone Payments (US$ m), December 2017 48
Table 27: Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, July 2017 - December 2017 51
Table 28: Pharmaceuticals & Healthcare, Global, Licensing Agreements by Therapy Area, by Upfront and Milestone Payments and Deal Values (US$ m), December 2017 53
Table 29: Pharmaceuticals & Healthcare, Global, Top Licensing Agreement Deals by Value, December 2017 53
Table 30: Pharmaceuticals & Healthcare, Global, Top Licensing Agreement Deals by Total Upfront Payments, December 2017 54
Table 31: Pharmaceuticals & Healthcare, Global, Top Licensing Agreement Deals by Total Milestone Payment, December 2017 54
Table 32: Pharmaceuticals & Healthcare, Global, Oncology, Deals Summary, Number of Deals and Deal Values (US$ m), July 2017 - December 2017 56
Table 33: Pharmaceuticals & Healthcare, Global, Central Nervous System, Deals Summary, Number of Deals and Deal Values (US$ m), July 2017 - December 2017 59
Table 34: Pharmaceuticals & Healthcare, Global, Infectious Diseases, Deals Summary, Number of Deals and Deal Values (US$ m), July 2017 - December 2017 62
Table 35: Pharmaceuticals & Healthcare, Global, Cardiovascular, Deals Summary, Number of Deals and Deal Values (US$ m), July 2017 - December 2017 65
Table 36: Pharmaceuticals & Healthcare, Global, Immunology, Deals Summary, Number of Deals and Deal Values (US$ m), July 2017 - December 2017 67
Table 37: Pharmaceuticals & Healthcare, Global, Gastrointestinal, Deals Summary, Number of Deals and Deal Values (US$ m), July 2017 - December 2017 69
Table 38: Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Deals Summary, Number of Deals and Deal Values (US$ m), July 2017 - December 2017 72
Table 39: Pharmaceuticals & Healthcare, North America, Deals Summary, Number of Deals and Deal Values (US$ m), July 2017 - December 2017 74
Table 40: Pharmaceuticals & Healthcare, Europe, Deals Summary, Number of Deals and Deal Values (US$ m), July 2017 - December 2017 77
Table 41: Pharmaceuticals & Healthcare, Asia-Pacific, Deals Summary, Number of Deals and Deal Values (US$ m), July 2017 - December 2017 80
Table 42: Pharmaceuticals & Healthcare, Rest of the World, Deals Summary, Number of Deals and Deal Values (US$ m), July 2017 - December 2017 82
Table 43: Pharmaceuticals & Healthcare, Top Financial Advisors, M&A, Number of Deals and Deal Values (US$ m), July 2017 - December 2017 84
Table 44: Pharmaceuticals & Healthcare, Global Top Financial Advisors, Equity Offerings, Number of Deals and Deal Values (US$ m), July 2017 - December 2017 85
 



List Of Figures

1.2 List of Figures
Figure 1: Pharmaceuticals & Healthcare, Global, Number of Deals and Deal Values (US$ m), July 2017 - December 2017 10
Figure 2: Pharmaceuticals & Healthcare, Global, Number Of Deals (%), December 2017 16
Figure 3: Pharmaceuticals & Healthcare, Global, Deal Values (%), December 2017 17
Figure 4: Pharmaceuticals & Healthcare, Global, M&As, Number of Deals and Deal Values (US$ m), July 2017 - December 2017 18
Figure 5: Pharmaceuticals & Healthcare, Global, M&As by Therapy Area, Number of Deals and Deal Values (US$ m), by Therapy Area, July 2017 - December 2017 20
Figure 6:Pharmaceuticals & Healthcare, Global, Equity Offering Deals, Number of Deals and Deal Values (US$ m), July 2017 - December 2017 21
Figure 7:Pharmaceuticals & Healthcare, Global, Equity Offering Deals by Therapy Area, Number of Deals and Deal Values (US$ m), July 2017 - December 2017 23
Figure 8:Pharmaceuticals & Healthcare, Global, Private Equity and Venture Capital, Number of Deals and Deal Values (US$ m), July 2017 - December 2017 24
Figure 9: Pharmaceuticals & Healthcare, Global, PE/VC Deals by Therapy Area, Number of Deals and Deal Values (US$ m), by Therapy Area, July 2017 - December 2017 26
Figure 10: Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, Number Of Deals (%), December 2017 27
Figure 11: Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, Deal Values (%), December 2017 28
Figure 12: Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, Number of Deals and Deal Values (US$ m), July 2017 - December 2017 29
Figure 13: Pharmaceuticals & Healthcare, Global, Partnerships, Number of Deals and Deal Values (US$ m), July 2017 - December 2017 31
Figure 14: Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, Number of Deals and Deal Values (US$ m), July 2017 - December 2017 32
Figure 15: Pharmaceuticals & Healthcare, Global, Partnership Deals, Upfront and Milestone Payments and Deal Values (US$ m), July 2017 - December 2017 33
Figure 16: Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, Upfront and Milestone Payments and Deal Values (US$ m), July 2017 - December 2017 35
Figure 17: Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, July 2017 - December 2017 37
Figure 18: Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, July 2017 - December 2017 38
Figure 19: Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), July 2017 - December 2017 39
Figure 20: Pharmaceuticals & Healthcare, Global, Licensing Agreements, Number of Deals and Deal Values (US$ m), July 2017 - December 2017 41
Figure 21: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront and Milestone Payments and Deal Values (US$ m), July 2017 - December 2017 43
Figure 22: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Number of Deals and Deal Values (US$ m), July 2017 - December 2017 45
Figure 23: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Upfront and Milestone Payments and Deal Values (US$ m), July 2017 - December 2017 47
Figure 24: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Number Of Deals, July 2017 - December 2017 49
Figure 25: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Deal Values (US$ m), July 2017 - December 2017 50
Figure 26: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, by Upfront and Milestone Payments and Deal Values (US$ m), December 2017 52
Figure 27: Pharmaceuticals & Healthcare, Global, Oncology, Number of Deals and Deal Values (US$ m), July 2017 - December 2017 55
Figure 28: Pharmaceuticals & Healthcare, Global, Central Nervous System, Number of Deals and Deal Values (US$ m), July 2017 - December 2017 58
Figure 29: Pharmaceuticals & Healthcare, Global, Infectious Diseases, Number of Deals and Deal Values (US$ m), July 2017 - December 2017 61
Figure 30: Pharmaceuticals & Healthcare, Global, Cardiovascular, Number of Deals and Deal Values (US$ m), July 2017 - December 2017 64
Figure 31: Pharmaceuticals & Healthcare, Global, Immunology, Number of Deals and Deal Values (US$ m), July 2017 - December 2017 66
Figure 32: Pharmaceuticals & Healthcare, Global, Gastrointestinal, Deals Summary, Number of Deals and Deal Values (US$ m), July 2017 - December 2017 68
Figure 33: Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Deals Summary, Number of Deals and Deal Values (US$ m), July 2017 - December 2017 71
Figure 34: Pharmaceuticals & Healthcare, North America, Number of Deals and Deal Values (US$ m), July 2017 - December 2017 73
Figure 35: Pharmaceuticals & Healthcare, Europe, Number of Deals and Deal Values (US$ m), July 2017 - December 2017 76
Figure 36: Pharmaceuticals & Healthcare, Asia-Pacific, Number of Deals and Deal Values (US$ m), July 2017 - December 2017 79
Figure 37: Pharmaceuticals & Healthcare, Rest of the World, Number of Deals and Deal Values (US$ m), July 2017 - December 2017 81
Figure 38: Pharmaceuticals & Healthcare, Global, Top Financial Advisors, M&A, Number of Deals and Deal Values (US$ m), July 2017 - December 2017 83
Figure 39: Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, Number of Deals and Deal Values (US$ m), July 2017 - December 2017 85
 



Partnerships, Licensing, Investments and M&A Deals and Trends for June 2018 in Pharmaceuticals GlobalDatas Partnerships, Licensing, Investments and M&A Deals and Trends for June 2018 in Pharmaceuticals report is an essential

View Report

Partnerships, Licensing, Investments and M&A Deals and Trends for May 2018 in Pharmaceuticals GlobalDatas Partnerships, Licensing, Investments and M&A Deals and Trends for May 2018 in Pharmaceuticals report is an essential

View Report

Partnerships, Licensing, Investments and M&A Deals and Trends for April 2018 in Pharmaceuticals GlobalDatas Partnerships, Licensing, Investments and M&A Deals and Trends for April 2018 in Pharmaceuticals , report is an essential

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports